查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722443

2025 年至 2033 年分子診斷市場報告（按產品、技術（聚合酶鍊式反應、雜交、DNA 定序、微陣列、等溫核酸擴增技術等）、應用、最終用戶和地區分類）

Molecular Diagnostics Market Report by Product, Technology (Polymerase Chain Reactions, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology, and Others), Application, End Users, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2024年全球分子診斷市場規模達209億美元。展望未來， IMARC Group預計到2033年市場規模將達到354億美元，2025-2033年期間的成長率（CAGR）為5.75%。傳染病和遺傳疾病的日益流行、聚合酶鏈反應（PCR）技術的進步、老齡化人口的不斷成長、早期疾病檢測意識的不斷增強以及政府的支持舉措都是影響市場發展軌蹟的因素。

分子診斷市場分析：

主要市場促進因素：分子診斷市場正在擴大，主要是由於慢性病和傳染病的增加，這反過來又導致對準確診斷方法的需求不斷成長。此外，基因組學和個人化醫療的不斷進步也促進了分子診斷市場的成長。

主要市場趨勢：實質趨勢包括對 PCR 的需求（因為它準確且快速）以及由於新方法和診斷技術導致的試劑和試劑盒的增加。此外，非侵入性、早期診斷方法的發展也支持了這項需求。

地理趨勢：北美由於擁有先進的醫療基礎設施、更多的研發投資以及對個人化醫療的高度重視而處於世界領先地位。此外，亞太地區透過增加資源使用量以及增加與健康相關的知識和支出，面臨快速發展。

競爭格局：持續為市場做出貢獻的主要競爭公司包括羅氏診斷、雅培實驗室、凱傑、Bio-Rad 實驗室、西門子醫療、賽默飛世爾科技等。這些企業大力投資新技術和合作夥伴關係，以保持分子診斷市場佔有率並佔領新領域。

挑戰與機會：障礙在於分子診斷的監管複雜性與資金。伴隨著挑戰，新興市場日益成長的醫療保健需求以及持續的技術進步也為醫療保健提供者帶來了新的機會，這些進步有望提供更好的診斷並擴大市場。

分子診斷市場趨勢：

慢性病和傳染病症率不斷上升

市場呈現出驚人的成長率，這主要是由於急性和慢性疾病病例的增加。癌症、心臟病和感染等疾病發生率的增加凸顯了分子診斷在快速正確診斷疾病方面的重要作用。這個屬性可以帶來更好的患者治療效果，並制定個人化治療計劃，從而增加了市場對分子診斷的需求。隨著世界各地健康狀況的日益複雜，對新型分子診斷設備的需求也不斷增加，這反過來又推動了市場的成長。根據衛生部報告，2016年非傳染性疾病佔全國死亡人數的61%，佔殘疾人數的55%。

基因組學和個人化醫療的技術進步

該行業正在經歷基因組學和個人化醫療的發展，這對全球分子診斷市場趨勢至關重要。 DNA 定序、基因表現和 RNA 等下一代 DNA 定序的基因分析創新至關重要，它們改變了診斷方式並允許識別特定的疾病標記和遺傳傾向。個人化醫療的利用，即根據個人的基因特徵制定治療方案，需要能夠準確解讀複雜基因資訊的複雜診斷技術。先進技術與個人化治療之間的持續合作正在擴大市場佔有率。

根據個人化醫療報道，2015年，美國總統歐巴馬啟動了精準醫療計畫（PMI）。該計劃為研究人員提供了安全存取大量基因組資料的機會，這些數據從數千個開始，可能擴展到一百萬個基因組序列，以進行深入的科學研究。

人口老化加劇，對針對性診斷的需求

由於老年族群中神經退化性疾病和心血管疾病等疾病的增多，對有效診斷方法的需求也在增加。分子診斷具有早期檢測健康狀況的寶貴功能，從而為便捷且改善療效的治療提供了清晰的途徑。這一人口結構的成長趨勢顯著增加了對晶片實驗室（LOA）技術等非侵入性和精確工具的需求，這表明越來越多的細分市場傾向於適應這一新的健康需求。這種人口轉變對分子診斷市場分析有重大貢獻。

分子診斷市場區隔：

按產品分類：

  • 試劑和試劑盒
  • 儀器
  • 軟體和服務

試劑和試劑盒佔據市場主導地位

由於分子診斷擴展到各個專業醫療領域，市場正在經歷顯著成長，特別是在試劑和試劑盒領域。研究的新範式和新發明產生了新的分析和測試方法，這些分析和測試方法需要適當的試劑和試劑盒才能實現。慢性病數量的不斷增加使得對快速可靠的診斷工具的需求變得更加重要，從而推動了慢性病數量的成長。大型公司與研究機構的合作也對新試劑和試劑盒的開發產生了影響，因此在增加分子診斷市場收入方面發揮了重要作用。

按技術分類：

  • 聚合酶鍊式反應（PCR）
  • 雜交
  • DNA定序
  • 微陣列
  • 等溫核酸擴增技術（INAAT）
  • 其他

聚合酶鍊式反應（PCR）佔據市場主導地位

PCR 領域在分子診斷市場前景中佔據主導地位。 PCR技術改進的出現，包括qPCR和dPCR的設計和構建，推動了擴增的生化過程，從而提高了靈敏度、準確性和速度。 PCR 的進步使其成為分子診斷中不可或缺的工具。精確分析基因圖譜對於個人化醫療和標靶治療至關重要。此外，即時診斷技術的進步和 PCR 平台的引入使醫療專業人員和患者能夠更輕鬆地進行分子檢測，從而擴大其在醫療環境中的整合。

按應用分類：

  • 傳染病診斷
  • 腫瘤學
  • 基因檢測
  • 血液篩檢
  • 其他

傳染病診斷佔市場主導地位

分子診斷市場概況解釋說，市場動態與傳染病的快速傳播一致，包括病毒、細菌和真菌感染。疾病的迅速傳播，特別是那些有可能使世界陷入大流行病的疾病，迫切需要早期檢測機制和使用可行的遏制策略。分子生物學和免疫測定技術在診斷領域的出現徹底改變了這一領域，提高了病原體檢測和抗藥性分類的準確性和速度。這項突破為分子診斷創造了一個有前景的市場，並預示著預防性保健和監測項目成長的強勁趨勢。這些措施對醫療介入、阻止疫情蔓延發揮了重要作用。

按最終用戶分類：

  • 醫院
  • 實驗室
  • 其他

按地區分類：

  • 北美洲
  • 美國
  • 加拿大
  • 亞太
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

北美佔據明顯優勢，佔最大的分子診斷市場佔有率

市場研究報告也對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。根據報告，北美是分子診斷最大的區域市場。

根據分子診斷市場預測期，北美市場因持續研發創新的強大文化而不斷成長。隨著癌症、心血管疾病、糖尿病等慢性疾病的發生率不斷上升，需要快速且可靠的檢測方法。醫療專業人員和患者對個人化醫療理解程度的提高以及其他因素正在推動市場成長。政府對醫療保健現代化的援助以及分子診斷技術的建立是業務成長的主要經濟驅動力。此外，DTC基因檢測也是提高消費者互動程度和支持分子診斷市場近期機會的重要組成部分。

（請注意，這只是關鍵參與者的部分列表，完整列表在報告中提供。）

主要的分子診斷公司正在參與該行業的最新趨勢，例如雅培實驗室和安捷倫科技公司。領先的生物製藥公司透過推出更新、更精確、經過更好測試的產品來推動診斷技術的改進。此外，全球巨頭正透過收購、合併和不同的合作方式繼續擴大其在各個地區的影響力，以增加其市場佔有率並促進進入新市場。這些策略舉措擴大了他們的產品線並提高了他們的活動質量，滿足了客製化和即時診斷的持續需求。分子診斷的最新發展包括人工智慧和機器學習技術的融合，可以更好地促進資料分析並提高診斷的準確性。

分子診斷市場新聞：

2023年5月，美國碧迪醫療公司宣布投資8,000萬美元在華雷斯城興建第三家工廠。

2023 年 1 月，安捷倫科技與 Akoya Biosciences 合作開發用於組織分析的多重免疫組織化學診斷產品。兩家公司也同意在臨床研究市場推廣多重檢測的端到端工作流程解決方案。

2023 年 4 月，雅培宣布收購心血管系統公司 (CSI)，這是一家醫療器材公司，擁有用於治療周邊和冠狀動脈疾病的創新動脈粥狀硬化切除系統。

本報告回答的關鍵問題

  • 分子診斷市場有多大
  • 分子診斷市場的未來前景如何
  • 推動分子診斷市場的關鍵因素有哪些
  • 哪個地區佔據最大的分子診斷市場佔有率
  • 全球分子診斷市場的領導公司有哪些

本報告回答的關鍵問題

  • 分子診斷市場有多大？分子診斷市場的未來前景如何？
  • 推動分子診斷市場發展的關鍵因素有哪些？
  • 哪個地區佔最大的分子診斷市場佔有率？
  • 全球分子診斷市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球分子診斷市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 試劑和試劑盒
  • 儀器
  • 軟體和服務

第7章：市場區隔：依技術

  • 聚合酶鍊式反應（PCR）
  • 雜交
  • DNA定序
  • 微陣列
  • 等溫核酸擴增技術（INAAT）
  • 其他

第 8 章：市場區隔：按應用

  • 傳染病診斷
  • 腫瘤學
  • 基因檢測
  • 血液篩檢
  • 其他

第9章：市場區隔：依最終用戶

  • 醫院
  • 實驗室
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • Biomerieux SA
    • Danaher Corporation
    • Diasorin Molecular LLC (DiaSorin SpA)
    • F. Hoffmann-La Roche AG (Roche Holding AG)
    • Hologic Inc.
    • Illumina Inc.
    • Myriad Genetics Inc.
    • Qiagen
    • Quidel Corporation
    • Thermo Fisher Scientific
Product Code: SR112025A5726

The global molecular diagnostics market size reached USD 20.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 35.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.75% during 2025-2033. The increasing prevalence of infectious diseases and genetic disorders, technological advancements in polymerase chain reaction (PCR), growing aging population, surging awareness of early disease detection, and supportive government initiatives are factors shaping the market's trajectory.

Molecular Diagnostics Market Analysis:

Major Market Drivers: The market for molecular diagnostics is expanding primarily due to rise in chronic and infectious illnesses which in turn is leading to growing demand for accurate diagnostics methods. In addition, the continual advancements in genomic and personalized medicine are contributing to the molecular diagnostics market growth.

Key Market Trends: Substantial trends include the demand for PCR as it is accurate and fast and the increase in reagents and kits due to the new methodologies and diagnostic technologies. Besides, the movement towards non-invasive, early diagnosis approaches is also supporting the demand.

Geographical Trends: North America is the leader in the world, due to the presence of advanced medical infrastructure, more investments in R&D and a great emphasis on personalized medicine. In addition, Asia-Pacific faces a fast development through increasing resource usage and more health-related knowledge and spendings.

Competitive Landscape: The key competitive companies that are constantly contributing to the market are Roche Diagnostics, Abbott Laboratories, QIAGEN, Bio-Rad Laboratories, Siemens Healthineers, and Thermo Fisher Scientific and others. These enterprises invest heavily in the new technologies and partnerships to maintain the molecular diagnostics market share and occupy new territories.

Challenges and Opportunities: The barriers are regulatory intricacies and finances of the molecular diagnostics. Along with the challenges, new opportunities emerge for healthcare providers from the growing healthcare needs in the emerging markets and from the constant technological advances which promise better diagnostics and expand the market.

Molecular Diagnostics Market Trends:

Increasing prevalence of chronic and infectious diseases

The market is exhibiting an outstanding growth rate which is mainly due to the increasing cases of acute and chronic illnesses. This increase in disease occurrence, including cancer, heart diseases, and infection focuses on the significant role of the molecular diagnostics in giving fast and proper diagnosis of the disease. This attribute enables the better patient outcomes and also constitutes individual response personalized treatment plans, which increases the molecular diagnostics demand in the market. Along with the expanding complexities of health conditions all over the world, the demand for newfangled molecular diagnostic equipment is rising, which in turn perpetuates the market growth. According to a report by the ministry of health, in 2016, non-communicable diseases (NCDs) accounted for 61% of all mortalities and 55% of disability cases.

Technological advancements in genomics and personalized medicine

The sector is experiencing developments in genomics and personalized medicine that are crucial for the global molecular diagnostics market trends. Genetic profiling innovations for DNA sequencing, gene expression, and next-generation DNA sequencing such as RNA are essential and changing the ways of diagnosis and allowing the identification of specific disease markers and genetic predispositions. The utilization of personalized medicine, which entails to tailoring treatment based on the individual's genetic profile, is creating a need for sophisticated diagnostic technologies, that is able to decipher complex genetic information accurately. The rising cooperation between sophisticated technologies and tailored treatments is expanding the market share.

According to the personalized medicine report, in 2015, U.S. President Barack Obama launched the precision medicine initiative (PMI). This initiative offers researchers secure access to an extensive array of genomic data, starting with thousands and potentially expanding to one million genome sequences, for in-depth scientific research.

Rising aging population and demand for targeted diagnostics

The demand for efficient diagnostic method is rising due to rising illnesses, such as neurodegenerative disorders and cardiovascular problems in geriatric populations. Molecular diagnostics offer a valuable functionality of early detection of health conditions, thus providing a clear path for treatment at convenient and improved outcomes. The growing trend of this demographic is significantly increasing demand for non-invasive and accurate tools such as lab-on-a-chip (LOA) technology which is indicative of an increasing market segment's inclination to adapt to this new health requirement. This population shift is a significant contributing to the molecular diagnostics market analysis.

Molecular Diagnostics Market Segmentation:

Breakup by Product:

  • Reagents and Kits
  • Instruments
  • Software and Services

Reagents and kits dominate the market

The market is experiencing a significant increase, particularly in the reagents and kits segment, due to the expansion of molecular diagnostics reach into various medical areas of specialization. Fresh paradigms in research and novel inventions generate novel assays and testing methods that require the appropriate reagents and kits to be feasible. The growing number of chronic diseases make the need for fast and dependable diagnostic tools more crucial, driving the increase. Involvement of the major companies with research institutions also has an impact on the development of new reagents and kits, and hence plays a significant part in increasing the molecular diagnostics market revenue.

Breakup by Technology:

  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

Polymerase chain reactions (PCR) dominate the market

The PCR segment is dominating the molecular diagnostics market outlook. The advent of PCR technology refinements, including the designing and constructing of qPCR and dPCR, propel the amplification's biochemical process, thereby improves the sensitivity, accuracy, and speed. Such advancement of PCR has made it an indispensable instrument in molecular diagnostics. Precise analysis of genetic profiles which can be used in personalized medicine and targeted therapies is now essential to these treatments. Besides, the point-of-care diagnostics advancement and PCR platform introduction into both of the healthcare professionals and patients make molecular testing more available this leads broaden its integration among healthcare environments.

Breakup by Application:

  • Infectious Diseases Diagnostics
  • Oncology
  • Genetic Testing
  • Blood Screening
  • Others

Infectious diseases diagnostics dominate the market

The molecular diagnostics market overview explains that the market dynamics are in line with rapid spread of infectious diseases, encompassing viral, bacterial, and fungal infections. The rapid spread of diseases, especially those which have the potential to plunge the world into pandemics, has caused an urgent need for early detection mechanism and the use of viable containment strategies. The advent of molecular biology and immunoassay technologies in diagnostics revolutionized this landscape by enhancing the accuracy and speed of pathogen detection and typing for their resistances. This breakthrough has led to the creation of a promising market for molecular diagnostics and indicates a strong trend of the growth of preventive health and surveillance projects. These measures play an important role in the medical involvement and stopping the spread of infections.

Breakup by End Users:

  • Hospitals
  • Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for molecular diagnostics.

North America market is growing due to the strong culture of perpetual research and development innovation, as per the molecular diagnostics market forecast period. With the increase in the development of chronic diseases, such as cancer, cardiovascular diseases and diabetes, the rapid and reliable detection methods are required. The increased level of personalized medicine understanding in healthcare professionals and patients alongside other factors is propelling the market growth. Development of government aid in the healthcare modernization and the establishment of molecular diagnostics techniques are the major economies drivers in the business growth. Furthermore, DTC genetic testing is also a significant part which improves the level of consumer interaction and supports the molecular diagnostics market recent opportunities.

Competitive Landscape:

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton Dickinson and Company
  • Biomerieux SA
  • Danaher Corporation
  • Diasorin Molecular LLC (DiaSorin)
  • F. Hoffmann-La Roche AG (Roche Holding AG)
  • Hologic Inc.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • Qiagen
  • Quidel Corporation
  • Thermo Fisher Scientific

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key molecular diagnostics companies are getting involved in the latest trends in the industry, such as Abbott Laboratories and Agilent Technologies Inc. Leading bio-pharmaceutical firms drive the improvements in diagnostic technology through introduction of newer, more precise, and better tested products. Besides, global giants are continuing to grow their presence across various regions with acquisitions, mergers, and different partnerships in order to increase their market share and facilitating the access to new markets. These strategic moves expand their product lines and improve the quality of their activity, catering to the all-time demand for a customized and point-of-care diagnoses. Molecular diagnostics recent developments include a merger of AI and machine learning technologies that better facilitate data analysis and enhance the accuracy of diagnostics.

Molecular Diagnostics Market News:

In May 2023, Becton Dickinson and Company announced to invest US$ 80 million in the construction of its third plant in Ciudad Juarez.

In January 2023, Agilent Technologies and Akoya Biosciences collaborated to develop multiplex-immunohistochemistry diagnostic products for tissue analysis. The companies also agreed to market end-to-end workflow solutions for multiplex assays in the clinical research market.

In April 2023, Abbott announced the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.

Key Questions Answered in This Report

  • 1.How big is the molecular diagnostics market?
  • 2.What is the future outlook of molecular diagnostics market?
  • 3.What are the key factors driving the molecular diagnostics market?
  • 4.Which region accounts for the largest molecular diagnostics market share?
  • 5.Which are the leading companies in the global molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reactions (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases Diagnostics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Genetic Testing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Blood Screening
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Users

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerieux SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Hologic Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Qiagen
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quidel Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2024
  • Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
  • Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million USD), 2025-2033
  • Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Molecular Diagnostics Market: Key Players